ACE2 and COVID-19: To investigate if the protein expression of ACE2 is alteredin the COVID-19-affected brain compared to the normal brain, we usedpostmortem tissue samples from 9 to 12 different brain regions correspondingto three patients experiencing varying degrees of neurological symptoms(Patient 1, 2, and 3).